ZOSTAVAX is not indicated for the treatment of zoster or postherpetic neuralgia. ZOSTAVAX should not be used for prevention of primary varicella infection. Find storage information for ZOSTAVAX® (Zoster Vaccine Live), including before reconstitution and the type of freezer and temperatures. ZOSTAVAX is indicated for prevention of herpes zoster (“zoster” or shingles) and herpes zoster-related Read the package leaflet before use. 6. SPECIAL.
|Published (Last):||26 May 2014|
|PDF File Size:||3.95 Mb|
|ePub File Size:||4.74 Mb|
|Price:||Free* [*Free Regsitration Required]|
Zoster vaccine efficacy wanes within the first 5 years after vaccination, and protection beyond 5 years is uncertain. Although the vaccine has short-term efficacy, there have been no long-term studies of vaccine protection in this age group. Also, healthcare providers may want to first consider whether the patients 50 through 59 years old would have poor tolerance to zoster or post-herpetic neuralgia symptoms. Use this handout to teach patients about the seriousness of shingles and the value of vaccination [ P].
One of the Recommended Vaccines by Disease.
Eligible health professionals may vaccinate adults who meet any of the criteria on this form [ P]. Protect yourself from shingles No data are available about the effectiveness of zoster vaccine in adults who become immunosuppressed after their vaccination. Therefore, people who receive the vaccine before 60 years old might not be protected when their risks for zoster and its complications are highest.
In people vaccinated at 60 years old or older, vaccine efficacy wanes within the first 5 years after vaccination, and protection beyond 5 years is uncertain. The vaccine should be administered immediately after reconstitution to minimize loss of potency.
The event should be documented and procedures put in place to prevent this from happening again. IAC Express – Subscribe. But anyone with a moderate or severe acute illness should usually wait insetr they recover before getting the vaccine. If the erroneous dose was administered in lieu of the first dose of varicella vaccine, a second dose of varicella vaccine is required at the normal time a second dose would be inssrt.
Persons who report that they have not had varicella can still receive the zoster vaccine.
Handouts: Vaccine Index
Honor Rolls for Patient Safety. Zoster vaccine is administered subcutaneously as a single dose. State Laws and Mandates. July 31, Page last updated: In the event that varicella vaccine was accidentally administered to an adult 60 years of age or older instead of zoster vaccine, Advisory Committee on Immunization Practices states: Unprotected People Reports – Shingles zoster. When administering zoster vaccine to people 60 years of age or older, there is no need to ask for a history of varicella or to conduct laboratory testing for serologic evidence of prior varicella-zoster virus infection.
Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content. Also, varicella vaccine should not be used in place of zoster vaccine. If a dose of zoster vaccine was given accidentally in place of varicella vaccine Varivax for a child or an adult, then that dose of zoster vaccine should be counted the same as a single valid dose of varicella vaccine.
Zoster vaccine should not be used in children and should not be used in place of varicella vaccine.
CDC answers your questions. Psckage 25, Content source: Furthermore, no laboratory evaluations exist to test for the previous occurrence of zoster, and any reported diagnosis or history might be erroneous. Standing orders for administering zoster vaccine to adults.
Zoster Vaccine – Patient Information Handouts – Shingles Vaccine Information
Vaccine Storage and Handling. Information about the disease and vaccine for patients and parents [ P]. Studies are ongoing to assess the duration of protection from one dose of zoster vaccine and the need, if any, for booster doses. Someone with a minor acute illness, such as a cold, may be vaccinated. The vaccine should not be injected intramuscularly.
There are no comprehensive data on the effectiveness of zoster vaccine in treating shingles once it occurs, and the vaccine is not licensed for this use. If serologic testing is conducted and there is evidence of varicella susceptibility, the patient should be offered varicella vaccine not zoster vaccine. The general guideline for any vaccine ijsert to wait until the acute stage of the illness is over and symptoms subside.